Your session is about to expire
← Back to Search
Study Summary
This trial seeks to test a mobile app intervention targeting African American smokers' sensitivity to interoceptive stress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing to keep the study app on my phone for a year.I am currently using medication or therapy to quit smoking not given by this study's team.I am 18 years old or older.I am currently receiving therapy for anxiety or depression.You should be ready to stop smoking two weeks after completing the initial survey and receiving study materials like nicotine replacement medications or iCO.I am willing and able to complete all required study surveys and assessments.You are 18 years or older, African American, and smoke at least 10 cigarettes per day for more than 2 years. You also have high anxiety sensitivity, which will be measured during a phone interview. You must be willing to quit smoking, use nicotine replacement therapy, and complete all study surveys and assessments.I am under 18 years old.I am not fluent in English.My high blood pressure is not controlled.I had a heart attack in the last 2 weeks.You are currently undergoing or planning to undergo treatment for substance abuse.You identify yourself as Black or African American.You are willing to use nicotine replacement therapy (NRT).I am motivated to quit smoking.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: MASP app + NRT
- Group 2: QuitGuide app + NRT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
What is the approximate enrollment rate of participants for this research?
"Affirmative. The clinical trial's details hosted on the website clinicaltrials.gov reveals that recruitment is still ongoing for this study, which was initially posted in December 2021 and recently updated in March 2022. A total of 225 patients are needed to be recruited from 3 different medical institutions."
Are enrollments for this trial currently being accepted?
"Affirmative. Clinicaltrials.gov displays that the study, initially posted on December 20th 2021, is currently recruiting individuals for enrollment - 225 people from 3 different locations in total."
Is there a way to become involved in this medical research endeavor?
"This investigation is in search of 225 individuals who smoke tobacco and are between 18 and 64 years old. Furthermore, they must be African American, have a high Anxiety sensitivity (SSASI score ≥ 5), consume a minimum of 10 cigarettes daily for the past two years or more, possess motivation to quit smoking (score >5 on a 10-point scale), agree to complete all pertinent surveys/assessments, accept use NRT products if necessary, and plan to abstain from smoking 2 weeks after baseline survey completion with accession of study materials such as iCOs an nicotine replacements medications."
Is the research study welcoming participants of advanced age?
"This research project requires participants to be between 18-64 years old. For those below this age, there are 4 separate trials available, and for those above it, 31 clinical studies can provide assistance."
What is the ultimate goal of this research project?
"The primary goal of this trial, which will be evaluated over a 6 week period (in phases 2 and 3), is to monitor the change in carbon monoxide levels at baseline using Carbon Monoxide Analysis. Secondary objectives include analyzing how stress related to COVID-19 can influence smoking outcomes; evaluating changes in anxiety sensitivity with a 5-point Short Scale Anxiety Sensitivity Index; and exploring if there are any underlying effects on stress caused by racial/ethnic discrimination through utilizing the Jackson Heart Study Discrimination Instrument."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger